Westwood Holdings Group Inc. Has $11.70 Million Holdings in Medtronic PLC $MDT

Westwood Holdings Group Inc. raised its position in Medtronic PLC (NYSE:MDT) by 8.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 134,161 shares of the medical technology company’s stock after purchasing an additional 10,342 shares during the quarter. Westwood Holdings Group Inc.’s holdings in Medtronic were worth $11,695,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Brighton Jones LLC grew its stake in shares of Medtronic by 1,368.0% during the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock worth $3,194,000 after acquiring an additional 37,265 shares in the last quarter. Vestmark Advisory Solutions Inc. lifted its position in shares of Medtronic by 98.4% in the first quarter. Vestmark Advisory Solutions Inc. now owns 8,746 shares of the medical technology company’s stock worth $786,000 after purchasing an additional 4,338 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Medtronic by 5.8% during the first quarter. EverSource Wealth Advisors LLC now owns 5,139 shares of the medical technology company’s stock worth $462,000 after purchasing an additional 284 shares during the last quarter. Nations Financial Group Inc. IA ADV grew its position in Medtronic by 2.9% in the first quarter. Nations Financial Group Inc. IA ADV now owns 8,114 shares of the medical technology company’s stock valued at $729,000 after purchasing an additional 232 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC increased its stake in Medtronic by 10.1% in the 1st quarter. Steward Partners Investment Advisory LLC now owns 251,680 shares of the medical technology company’s stock valued at $22,616,000 after buying an additional 23,120 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on MDT shares. Weiss Ratings restated a “buy (b)” rating on shares of Medtronic in a research note on Monday, December 8th. Citigroup increased their price target on Medtronic from $101.00 to $112.00 and gave the company a “buy” rating in a research report on Tuesday, October 7th. Robert W. Baird raised their price target on Medtronic from $103.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, November 19th. Daiwa Capital Markets upped their price objective on Medtronic from $104.00 to $117.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Finally, Piper Sandler reissued a “neutral” rating on shares of Medtronic in a report on Friday, November 14th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $110.44.

Medtronic Price Performance

NYSE:MDT opened at $99.86 on Monday. Medtronic PLC has a 12-month low of $79.29 and a 12-month high of $106.33. The firm has a market capitalization of $128.02 billion, a price-to-earnings ratio of 26.92, a P/E/G ratio of 2.63 and a beta of 0.71. The stock’s 50 day moving average price is $97.27 and its two-hundred day moving average price is $92.96. The company has a quick ratio of 1.80, a current ratio of 2.42 and a debt-to-equity ratio of 0.57.

Medtronic (NYSE:MDT) last issued its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, topping the consensus estimate of $1.31 by $0.05. The company had revenue of $8.96 billion during the quarter, compared to the consensus estimate of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.The firm’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, analysts anticipate that Medtronic PLC will post 5.46 earnings per share for the current year.

Medtronic Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic’s dividend payout ratio (DPR) is presently 76.55%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.